Room for Improvement: A 20-Year Single Center Experience with Allogeneic Stem Cell Transplantation for Myelodysplastic Syndromes

Allogeneic stem cell transplantation (allo-SCT) remains the only curative therapeutic approach for patients with myelodysplastic syndromes (MDS). The aim of the study was to assess the efficacy/safety of allo-SCT as well as to identify factors influencing post-transplant survival. One hundred and tw...

Descripción completa

Detalles Bibliográficos
Autores principales: Duda, Katarzyna, Wieczorkiewicz-Kabut, Agata, Spałek, Adrianna, Koclęga, Anna, Kopińska, Anna J., Woźniczka, Krzysztof, Helbig, Grzegorz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer India 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9569268/
https://www.ncbi.nlm.nih.gov/pubmed/36258723
http://dx.doi.org/10.1007/s12288-021-01508-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9569268/
https://www.ncbi.nlm.nih.gov/pubmed/36258723
http://dx.doi.org/10.1007/s12288-021-01508-8

Ejemplares similares